SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001493152-21-029889
Filing Date
2021-11-24
Accepted
2021-11-24 19:37:14
Documents
1
Period of Report
2021-10-22

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 11223
  Complete submission text file 0001493152-21-029889.txt   12701
Mailing Address 300 W. 41ST STREET SUITE 202 MIAMI BEACH FL 33140
Business Address 300 W. 41ST STREET SUITE 202 MIAMI BEACH FL 33140 (305) 204-3338
SAB Biotherapeutics, Inc. (Issuer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2100 E 54TH STREET NORTH SIOUX FALLS SD 57106
Business Address
Bausch Christoph Lawrence (Reporting) CIK: 0001889981 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39871 | Film No.: 211448796